Official profile for Bayer in the United States. Advancing science that delivers for people in America. Health for All, Hunger for None is what drives us.
+++NEWS+++ The U.S. Food and Drug Administration (FDA) has approved our treatment for adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D).
Learn more: bayer.com/en/us/news-stories…
What if American farms could help fuel the planes overhead and the trucks on the road? 🌾Bayer and @bp_plc are making it real – scaling newgold® camelina as a feedstock for renewable diesel and sustainable aviation fuel across North America.
bayer.com/en/us/news-stories…
#TeamBayer presented new late-breaking data from our Phase III OCEANIC-STROKE study today at #ESOC2026. We are committed to sharing insights that help drive impact in this area of unmet need.
Learn more: bayer.com/en/us/news-stories…
ALT NEWS: Bayer presents additional results from Phase III OCEANIC-STROKE study at ESOC 2026.
#News: We intend to acquire Perfuse Therapeutics, a biopharmaceutical company focused on ischemia-induced ocular diseases. Acquisition complements our pharmaceutical pipeline & reinforces our commitment to developing urgently needed therapies for patients: bayer.com/media/en-us/
Each year, stroke affects millions worldwide and can lead to lasting effects, including impaired mobility and loss of speech or vision. Hear from @ChaturvediNeuro on the unmet needs in secondary stroke prevention.
#TeamBayer#StrokePrevention
We‘re proud to see our secondary stroke prevention research published in @NEJM, initially presented at the International Stroke Congress 2026. This publication reflects our continued focus on advancing science for patients at risk of secondary stroke.
bayer.com/en/us/news-stories…
Update on Roundup Litigation: Today, a proposed U.S. nationwide class settlement was announced, designed to resolve eligible current and future RoundupTM claims through a long-term claims program. More details can be found in the link below. piped.video/d0hIMgwy1Nw
Today #TeamBayer presented results from our Phase III OCEANIC-STROKE study at #ISC26. We’re excited to contribute the latest data in an area of unmet need for the stroke community.
Read more: bit.ly/4kkApzt
Come see us at #ISC26! #TeamBayer will be presenting results from our Phase III OCEANIC-STROKE study during two late-breaking sessions.
We are excited to contribute to the research in stroke care.
Learn more: bit.ly/4klApj3
The U.S. Supreme Court today announced that it will review the Durnell Roundup case. The company expects a decision on the merits during the Court’s 2026 session, which ends in June.
Link to press release: bayer.com/media/en-us/bayer-…
As part of our commitment to support the communities we call home, Bayer is making a donation of $100,000 to support recovery efforts to @RedCross, @UnitedWaySTL and @ulstl from the devastating tornadoes that recently hit the St. Louis region.
Exciting news!🌽 Bayer's #Preceon Smart Corn System is set to change farming. With its ability to withstand winds up to 50 mph and increased planting density, farmers are ready for a sustainable future! 🌱 Read more: bit.ly/3XWhRvR#ShortCorn#AgInnovation
#TeamBayer brought Take Care, Now to the first weekend of @LukeBryan Farm Tour! We're proud to celebrate American farmers while educating about health and nutrition in rural America. #HeresToTheFarmer
Last week, #TeamBayer explored allergy disparities in America at the Congressional Black Caucus Foundation's annual conference. At Bayer, we aim to bring Health for all by reducing allergy risks and improving access to over-the-counter nasal allergy medications.
ONE WEEK until Farm Tour 2024 with @lukebryan!👏 We're proud to celebrate American farmers and bring nutritious foods and vitamins to rural communities in need.
Use #HeresToTheFarmer to show your support, and we hope to see you on the farm. #TeamBayer#Nutrition